P
Per-Anders Jansson
Researcher at University of Gothenburg
Publications - 121
Citations - 10151
Per-Anders Jansson is an academic researcher from University of Gothenburg. The author has contributed to research in topics: Type 2 diabetes & Insulin resistance. The author has an hindex of 47, co-authored 113 publications receiving 9299 citations. Previous affiliations of Per-Anders Jansson include Sahlgrenska University Hospital & National Institute of Occupational Health.
Papers
More filters
Journal ArticleDOI
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
Timothy E. Graham,Qin Yang,Matthias Blüher,Ann Hammarstedt,Theodore P. Ciaraldi,Robert R. Henry,Christopher J. Wason,Andreas Oberbach,Per-Anders Jansson,Ulf Smith,Barbara B. Kahn +10 more
TL;DR: RBP4 is an adipocyte-secreted molecule that is elevated in the serum before the development of frank diabetes and appears to identify insulin resistance and associated cardiovascular risk factors in subjects with varied clinical presentations, providing a rationale for antidiabetic therapies aimed at lowering serum RBP4 levels.
Journal ArticleDOI
Inhibition of Dipeptidyl Peptidase-4 Reduces Glycemia, Sustains Insulin Levels, and Reduces Glucagon Levels in Type 2 Diabetes
TL;DR: Improved metabolic control by DPP-4 inhibition in type 2 diabetes is seen in association with reduced glucagon levels and, despite the lower glycemia, unaltered insulin levels.
Journal ArticleDOI
A microdialysis method allowing characterization of intercellular water space in humans
TL;DR: It is concluded that this microdialysis technique is a useful tool allowing measurements of metabolically active substances in the intercellular water space in vivo provided that the calibrations are properly performed.
Journal ArticleDOI
Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes.
Bo Ahrén,Erik Simonsson,Hillevi Larsson,Mona Landin-Olsson,Hlin Torgeirsson,Per-Anders Jansson,Madeléne Sandqvist,Peter Båvenholm,Suad Efendic,Jan W. Eriksson,Sheila Dickinson,David Holmes +11 more
TL;DR: In inhibition of DPP IV is a feasible approach to the treatment of type 2 diabetes in the early stage of the disease, as concluded in a placebo-controlled double-blind multicenter study.
Journal ArticleDOI
Impact of an Exercise Intervention on DNA Methylation in Skeletal Muscle From First-Degree Relatives of Patients With Type 2 Diabetes
Marloes Dekker Nitert,Tasnim Dayeh,Peter Volkov,Targ Elgzyri,Elin Hall,Emma Nilsson,Beatrice T. Yang,Stefan Lang,Hemang Parikh,Ylva Wessman,Holger Weishaupt,Joanne L. Attema,Mia Abels,Nils Wierup,Peter Almgren,Per-Anders Jansson,Tina Rönn,Ola Hansson,Karl-Frederik Eriksson,Leif Groop,Charlotte Ling +20 more
TL;DR: DNA methylation of genes in biological pathways including mitogen-activated protein kinase (MAPK), insulin, and calcium signaling and of individual genes with known function in muscle found in skeletal muscle of FH+ compared with FH− men are found.